|Bid||0.0000 x 2900|
|Ask||0.0000 x 21500|
|Day's range||3.4550 - 3.7000|
|52-week range||3.3150 - 35.5100|
|Beta (5Y monthly)||1.88|
|PE ratio (TTM)||N/A|
|Earnings date||01 Aug 2022 - 05 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||16.18|
Biotech companies spend a lot of money. They spend it on research and development, clinical trials, and (if they are lucky) marketing and a salesforce. Bringing a new pharmaceutical or medical device to market is an expensive proposition.
Chevron, The Andersons, KB Home, Shopify and Invitae have been highlighted in this Value Investor article.
First published 73 years ago, the Intelligent Investor is still considered a must-read for value investors.